Research and Markets: World Market Report for Veterinary Diagnostics
Enzo Biochem to Request Rehearing of Court of Appeals Decision
Research and Markets: Emerging IVD and Molecular Market Assessment in Mexico
Continued technology advancements and market expansion support Illumina's narrow moat.
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
While a majority of our top fund managers are outperforming this year, three of them truly stand out from the rest given their ability to outperform the market over all time periods.
Widening investment-grade credit spreads and rising interest rates lead to losses.
Get our sector-by-sector take on the bond market, plus our five best bond ideas.